In the latter stages of maturation, however, more invasive measures are warranted to adequately determine IS in clinical practice.
Future studies with greater numbers of untreated RA patients are warranted to adequately substantiate and dissect these questions further.
However, further investigation to determine the direct effects of curcumin on colonic mucosa are warranted to adequately assess the efficacy of curcumin as a colorectal cancer chemopreventive agent.
In addition, interventions may be warranted to reduce injury incidence.
Therefore, the generation of CLC mutants in type A strains is warranted to determine if such mutants are adequately attenuated and capable of inducing a protective immune response against type A strains.
Rigorously designed and adequately powered randomized trials are warranted to (1) determine the effectiveness of promising approaches and (2) identify the interventions that are most effective in treating CRF in specific subpopulations (eg, stem cell transplant recipients, older adults, patients with lung or colorectal cancers, survivors, and those at the end of life).
The impact of our trial is likely to be important since the available evidence in this field is still limited, and new larger studies, adequately designed and conducted, are warranted to clarify the effectiveness of these strategies.
Future larger and more adequately powered prospective studies are warranted to clarify the assay standardization, the optimal cut-off, and the prognostic value of BNPs in conjunction with other biomarkers.
Larger adequately powered prospective studies are warranted to clarify the assay standardization, the optimal cut-off, and the prognostic value of BNPs in conjunction with other biomarkers in future.
A prospective randomized controlled trial, powered to adequately assess similar morbidity and mortality rates is warranted to confirm these findings.
